Floor | 3F | 5F | 6F |
---|
Room | Room 1 | Room 2 | Room 3 | Room 4 | Room 5 |
---|
08:00 - 09:00 | BREAKFAST SYMPOSIUM 1 | BREAKFAST SYMPOSIUM 2 | BREAKFAST SYMPOSIUM 3 | | |
09:00 - 09:30 | PLENARY LECTURE 1 What's new in epidemiology of ASCVD & risk factorsRaul Santos (University of São Paulo, Brazil) |
09:30 - 09:40 | BREAK |
09:40 - 11:15 | SYMPOSIUM 1 Emerging risk factors for atherosclerosis | SYMPOSIUM 2 Risk assessment for primary prevention | SYMPOSIUM 3 Clinical implication of genetic/epigenetic studies on coronary artery disease & dyslipidemia | SYMPOSIUM 4 Immune cells in blood vessels | SYMPOSIUM 5 New look at smooth muscle cells in atherosclerosis |
11:15 - 11:25 | COFFEE BREAK |
11:25 - 11:35 | OPENING ADDRESS |
11:35 - 12:05 | PLENARY LECTURE 2 Single cell RNA and antibody sequencing in women and men with cardiovascular diseaseKlaus Ley (La Jolla Institute for Immunology, USA) |
12:05 - 13:05 | LUNCHEON SYMPOSIUM 1 | LUNCHEON SYMPOSIUM 2 | LUNCHEON SYMPOSIUM 3 | LUNCHEON SYMPOSIUM 4 | |
13:05 - 14:05 | | | | ORAL PRESENTATION 1 | ORAL PRESENTATION 2 |
14:05 - 14:35 | PLENARY LECTURE 3 Optimal medical therapy to inhibit coronary plaqueKenichi Hirata (Kobe University, Japan) |
14:35 - 14:45 | COFFEE BREAK |
14:45 - 16:20 | SYMPOSIUM 6 TG metabolism & lipolysis | SYMPOSIUM 7 Imaging of atherosclerosis | SYMPOSIUM 8 Role of endothelial cells & ROS in atherosclerosis | SYMPOSIUM 9 Korean Dietary Reference Intakes(KDRI) for chronic disease risk reduction | |
16:20 - 17:55 | SYMPOSIUM 10 Principles & limitation of current lipid-lowering therapy | SYMPOSIUM 11 Latest trend of lipid modifying strategies | SYMPOSIUM 12 Influence of metabolic dysfunction in atherosclerosis | SYMPOSIUM 13 New techniques in basic atherosclerosis research |
18:00 - | DINNER |